Biohit Oyj Stock Exchange Release August 26, 2016 at 09:30 am local time (EEST)
Ilari Patrakka has been appointed Biohit Oyj’s Sales and Marketing Director and as a member of the Management Team as of August 26th 2016. He holds a Master of Science (M.Sc.) degree in Business Administration.
CEO Semi Korpela, Biohit Oyj: ‘Ilari Patrakka has over ten years of versatile experience in demanding sales and marketing roles in international technology companies out of which four years he has been working in Biohit Oyj.’
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com